Logo-jre
J Renal Endocrinol. 2021;7(1): e14.
  Abstract View: 82
  PDF Download: 50

Original Article

Outbreak and impact of coronavirus disease 2019 (COVID-19) on dialysis patients; Al Khezam dialysis center experience, Kuwait

Emad Abdallah * ORCID logo, Bassam Al Helal, Reem Asad, George Nessim, Shaikha Al-Bader, Yasser Elsharkawi, Ahmed Elmasry, Mohamed Abdelgelil, Essam Allam, Sahar Abdelkareem, Mohammad Kamal, Mohamed Hemida, Yasser Shaaban, Zeinab Zeid, Amr Saad, Abuhashem Ahmed

1 Al Khezam Dialysis Center, Al Adan Hospital, Kuwait.
*Corresponding Author: Professor Emad Abdallah, Email: drabdallah96@gmail.com

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is an outbreak due to SARS-CoV-2, declared by the World Health Organization (WHO) as a global pandemic in March 2020. Patients with underlying diseases, such as those with end-stage kidney disease (ESKD) on dialysis, are at greater risk.

Objectives: The aim of our study to assess the outbreak and impact of COVID-19 on dialysis patients.

Patients and Methods: Our study prospectively assessed and followed 442 patients with ESKD undergoing dialysis [390 patients on maintenance hemodialysis (HD) and 52 patients on peritoneal dialysis (PD)] for outbreak and impact of COVID-19 on these patients during the period from April 22, 2020 until March 23, 2021 in Al Khezam dialysis center, Kuwait. Age, gender, nationality, original kidney disease, history of hypertension (HTN), diabetes mellitus (DM), ischemic heart disease (IHD), congestive heart failure (CHF), bronchial asthma (BA), chronic obstructive pulmonary disease (COPD), history of pulmonary embolism (PE) and source of infection were analyzed. Symptoms as fever, fatigue, cough, loss of smell and taste and chest pain were recorded, the need for ICU admission, mechanical ventilation (MV), extracorporeal membrane oxygenation (ECMO), medications were recorded. The need to shift to continuous renal replacement therapy (CRRT) and outcomes (complications and mortality) were analyzed.

Results: Our study reported that 102 out of 442 (23%) dialysis patients [97 out of 390 (24.8%) HD patients and 5 out of 52 (9.6%) PD patients] got infected with COVID-19 and reinfection reported in 4 out of 97 (4%) COVID-19 HD patients. Around 27% of COVID-19 HD patients had fever, 19% had fatigue, 8% had cough, 4% had loss of smell, 4% had loss of taste, 4% had chest pain and 40% of COVID-19 PD patients had fever. Fifteen out of 97 (15 %) COVID-19 HD patients needed ICU admission, 12 out of 97 (12 %) COVID-19 HD patients needed MV. A 33 out of 97 (34%) COVID-19 HD patients and 4 out of 5 (80%) COVID-19 PD patients needed to switch to CRRT. Mortality was 17 (15 HD and 2 PD) out of 102 (16.6 %) COVID-19 dialysis patients and common causes of death were sepsis, myocardial infarction (MI), heart failure and PE.

Conclusion: Outbreak and mortality of COVID-19 infection is high in ESKD patients undergoing dialysis compared with general populations. Strict protocol for prevention of COVID-19 should be undertaken in dialysis centers and encourage of home dialysis and highly protective COVID-19 vaccination priority for dialysis patients.

Keywords: COVID-19, Hemodialysis, Peritoneal dialysis
Citation: Abdallah E, Al Helal B, Asad R, Nessim G, Al-Bader SH, Elsharkawi Y, Elmasry A, Abdelgelil M, Allam E, Abdelkareem S, Kamal M, Hemida M, Shaaban Y, Zeid Z, Saad A, Ahmed A. Outbreak and impact of coronavirus disease 2019 (COVID-19) on dialysis patients; Al Khezam dialysis center experience, Kuwait. J Renal Endocrinol. 2021;7:e14.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 82

Your browser does not support the canvas element.


PDF Download: 50

Your browser does not support the canvas element.